Characterization of Antigen Escape Mutations in Chronic HBV-Infected Patients in Upper Egypt

References

• Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–1129. doi:10.1056/NEJMra03108715014185
   PubMed Web of Science ®Google Scholar
• Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh MP. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microb Pathog. 2019;128:184–194. doi:10.1016/j.micpath.2019.01.00430611768
   PubMed Web of Science ®Google Scholar
• CfDAWA C. Estimates of the coverage of diagnosis and treatment for hepatitis B and C virus infection, by WHO region and income group. Global hepatitis report 2017. Geneva: World Health Organization; 2018. (WHO/CDS/HIV/1847) 2015.
   Google Scholar
• Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64(1):51–68.10704474
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Ludgate L, Hu J. Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol. 2008;216(2):289–294. doi:10.1002/jcp.2141618302164
   PubMed Web of Science ®Google Scholar
• Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol. 2010;52(4):514–522. doi:10.1016/j.jhep.2010.01.01420207438
   PubMed Web of Science ®Google Scholar
• Kao J-H. Diagnosis of hepatitis B virus infection through serological and virological markers. J Exp Rev Gastroenterol Hepatol. 2008;2(4):553–562. doi:10.1586/17474124.2.4.553
   PubMedGoogle Scholar
• Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336(8711):325–329. doi:10.1016/0140-6736(90)91874-A1697396
   PubMed Web of Science ®Google Scholar
• Simon K, Lingappa VR, Ganem D. Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor. J Cell Biol. 1988;107(6 Pt 1):2163–2168. doi:10.1083/jcb.107.6.21633198683
   PubMed Web of Science ®Google Scholar
• Eble B, Lingappa V, Ganem D. Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. J Mol Cell Biol. 1986;6(5):1454–1463. doi:10.1128/MCB.6.5.1454
   Web of Science ®Google Scholar
• Brown SE, Howard CR, Zuckerman AJ, Steward MW. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet. 1984;2(8396):184–187. doi:10.1016/S0140-6736(84)90479-36146750
   PubMed Web of Science ®Google Scholar
• Okamoto H, Yano K, Nozaki Y, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. J Pediatr Res. 1992;32(3):264–268. doi:10.1203/00006450-199209000-00002
   PubMed Web of Science ®Google Scholar
• Oon C. Evolution and transmission of hepatitis B virus mutants. J Hepatitis B Asia-Pacific Region London Royal College Physicians. 1997;177–190.
   Google Scholar
• El Chaar M, Candotti D, Crowther RA, Allain JP. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology. 2010;52(5):1600–1610. doi:10.1002/hep.2388620815025
   PubMed Web of Science ®Google Scholar
• Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother. 2008;61(4):766–768. doi:10.1093/jac/dkn01418218641
   PubMed Web of Science ®Google Scholar
• Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol. 2002;25(2):97–106. doi:10.1016/S1386-6532(02)00049-512367644
   PubMed Web of Science ®Google Scholar
• Ismail SA, Cuadros DF, Benova L. Hepatitis B in Egypt: a cross-sectional analysis of prevalence and risk factors for active infection from a nationwide survey. Liver Int. 2017;37(12):1814–1822. doi:10.1111/liv.1346928481452
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555. doi:10.1016/S0140-6736(15)61412-X26231459
   PubMed Web of Science ®Google Scholar
• El-Mokhtar MA, Seddik MI, Osman AOB, et al. No evidence of HEV genotype 1 infections harming the male reproductive system. Virology. 2021;554:37–41. doi:10.1016/j.virol.2020.12.00233360325
   PubMed Web of Science ®Google Scholar
• Sayed IM, El-Mokhtar MA, Mahmoud MAR, et al. Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt. Infect Drug Resist. 2021;14:59–69. doi:10.2147/IDR.S28976633469320
   PubMed Web of Science ®Google Scholar
• Al Baqlani SA, Sy BT, Ratsch BA, et al. Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman. PLoS One. 2014;9(5):e97759. doi:10.1371/journal.pone.009775924835494
   PubMed Web of Science ®Google Scholar
• Hoan NX, Hoechel M, Tomazatos A, et al. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. Viruses. 2021;13:2. doi:10.3390/v13020346
   Web of Science ®Google Scholar
• Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 1995;13(8):699–702. doi:10.1016/0264-410X(94)00080-77483783
   PubMed Web of Science ®Google Scholar
• Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol. 2005;32(2):102–112. doi:10.1016/j.jcv.2004.10.00815653412
   PubMed Web of Science ®Google Scholar
• Ma Q, Wang Y. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol. 2012;84(2):198–206. doi:10.1002/jmv.2318322170538
   PubMed Web of Science ®Google Scholar
• Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology. 2001;34(2):432–435. doi:10.1053/jhep.2001.2676411481631
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30(5):1312–1317. doi:10.1002/hep.51030051110534356
   PubMed Web of Science ®Google Scholar
• Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995;345(8962):1406–1407. doi:10.1016/S0140-6736(95)92599-67539089
   PubMed Web of Science ®Google Scholar
• Locarnini S, McMillan J, Bartholomeusz A. The hepatitis B virus and common mutants. Semin Liver Dis. 2003;23(1):5–20. doi:10.1055/s-2003-3758712616447
   PubMed Web of Science ®Google Scholar
• Bock CT, Tillmann HL, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology. 2002;122(2):264–273. doi:10.1053/gast.2002.3101511832441
   PubMed Web of Science ®Google Scholar
• Abu Zeid WM, Ramadan DI, Shemis MA. Prevalence of mutations within major hydrophilic region of hepatitis B virus and their correlation with genotypes among chronically infected patients in Egypt. Arab J Gastroenterol. 2016;17(1):34–40. doi:10.1016/j.ajg.2016.03.00127055927
   PubMed Web of Science ®Google Scholar
• Kishk R, Nemr N, Elkady A, et al. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J. 2015;12:153. doi:10.1186/s12985-015-0389-y26420301
   PubMed Web of Science ®Google Scholar
• Zaky S, Farghaly AM, Rashed HA, et al. Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt. Cell Immunol. 2010;265(2):97–104. doi:10.1016/j.cellimm.2010.07.00820719306
   PubMed Web of Science ®Google Scholar
• Elbahrawy A, Alaboudy A, El Moghazy W, Elwassief A, Alashker A, Abdallah AM. Occult hepatitis B virus infection in Egypt. World J Hepatol. 2015;7(12):1671–1678. doi:10.4254/wjh.v7.i12.167126140086
   PubMedGoogle Scholar
• Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res. 2007;37(s1):S20–26. doi:10.1111/j.1872-034X.2007.00099.x17627630
   PubMed Web of Science ®Google Scholar
• Zekri AR, Hafez MM, Mohamed NI, et al. Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. Virol J. 2007;4:74. doi:10.1186/1743-422X-4-7417631684
   PubMed Web of Science ®Google Scholar
• Lazarevic I, Banko A, Miljanovic D, Cupic M. Immune-Escape Hepatitis B Virus mutations associated with viral reactivation upon immunosuppression. Viruses. 2019;11(9):778. doi:10.3390/v11090778
   Web of Science ®Google Scholar
• Echevarría JM, Avellón A. Hepatitis B virus genetic diversity. J Med Virol. 2006;78(Suppl 1):S36–42. doi:10.1002/jmv.2060516622876
   PubMed Web of Science ®Google Scholar
• Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20(24):7653–7664. doi:10.3748/wjg.v20.i24.765324976703
   PubMed Web of Science ®Google Scholar
• Elkady A, Iijima S, Aboulfotuh S, et al. Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt. World J Hepatol. 2017;9(9):477–486. doi:10.4254/wjh.v9.i9.47728396718
   PubMedGoogle Scholar
• Mansour E, Abdul-Rahim S, Batouty G, Zaghloul I, Abdel-Hadi S. Integration of hepatitis B immunization in the expanded program on immunization of the child survival project. J Egypt Public Health Assoc. 1993;68(5–6):487–494.7775876
   PubMedGoogle Scholar
• Colson P, Borentain P, Motte A, et al. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology. 2007;367(1):30–40. doi:10.1016/j.virol.2007.05.01217573090
   PubMed Web of Science ®Google Scholar
• Kwak M-S, Chung G-E, Yang JI, Yim JY. Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B. Sci Rep. 2019;9(1):19417. doi:10.1038/s41598-019-56015-831857656
   PubMed Web of Science ®Google Scholar
• Di Lello FA, Ridruejo E, Martínez AP, Pérez PS, Campos RH, Flichman DM. Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure. J Viral Hepat. 2019;26(5):552–560. doi:10.1111/jvh.1305230576055
   PubMed Web of Science ®Google Scholar